Meta-analyses of genetic studies on major depressive disorder
- S. Lopez-León, A. Janssens, C. Duijn
- BiologyMolecular Psychiatry
- 1 August 2008
All MDD case–control genetic association studies published before June 2007 are reviewed and meta-analyses for polymorphisms that had been investigated in at least three studies that found statistically significant associations are performed.
The neuroactive potential of the human gut microbiota in quality of life and depression
- M. Valles-Colomer, G. Falony, J. Raes
- BiologyNature Microbiology
- 4 February 2019
Correlation of microbiome features with host quality of life and depression identified specific taxa and microbial pathways in two independent, large population cohorts, identifying links between microbial neuroactive potential and depression.
Glucocorticoid Receptor Gene-Based SNP Analysis in Patients with Recurrent Major Depression
This study suggests that polymorphisms in the 5′ region of the NR3C1 gene may play a role in the genetic vulnerability for MDD.
Reduced Reward Learning Predicts Outcome in Major Depressive Disorder
- E. Vrieze, D. Pizzagalli, S. Claes
- Psychology, BiologyBiological Psychiatry
- 1 April 2013
Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: Bipolar disorder.
- R. Segurado, S. Detera-Wadleigh, N. Akarsu
- PsychologyAmerican Journal of Human Genetics
- 1 July 2003
The present results for the very narrow model are promising but suggest that more and larger data sets are needed to support linkage, as well as suggest that linkage might be detected in certain populations or subsets of pedigrees.
A biopsychosocial model as a guide for psychoeducation and treatment of depression
- C. Schotte, B. Van den Bossche, D. De Doncker, S. Claes, P. Cosyns
- PsychologyDepression and Anxiety
- 2006
The model stresses the self‐evident integration of biological and psychological therapeutic interventions that need to focus on symptom reduction and on relapse prevention, and offers the patient and therapist a psychoeducational context in which the individual's vulnerability and depressive symptoms can be treated.
Relationship between P-glycoprotein and second-generation antipsychotics.
- T. Moons, M. D. de Roo, S. Claes, G. Dom
- Medicine, PsychologyPharmacogenomics (London)
- 15 August 2011
An internet search for all relevant English original research articles concerning P-gp and second-generation antipsychotics (SGAs) found some variability in the findings concerning adverse effects, and no definitive conclusions can be drawn.
A major SNP haplotype of the arginine vasopressin 1B receptor protects against recurrent major depression
- D. West, J. Del-Favero, S. Claes
- Biology, MedicineMolecular Psychiatry
- 15 September 2003
The data support a protective effect of this major haplotype for recurrent major depression, defined by alleles A-T-C-A-G for the AVPR1b-s SNPs s1-s2-s3-s4-s5 was significantly over-represented in controls compared to patients.
The dopamine D4 receptor gene 48-base-pair-repeat polymorphism and mood disorders: A meta-analysis
- S. L. Leon, E. Croes, F. Sayed-Tabatabaei, S. Claes, C. Broeckhoven, C. Duijn
- Psychology, MedicineBiological Psychiatry
- 1 May 2005
...
...